HEIDELBERG, Germany, March 7 -- EMBO Molecular Medicine, a peer-reviewed journal that says it features clinical research and basic biology, published research articles on the following topics in its March 7, 2022 edition:

Articles:

* Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis

* Blockade of the pro-fibrotic reaction mediated by the miR-143/-145 cluster enhances the responses to targeted therapy in melanoma